William P. Sheridan
2018
Compensation breakdown
| Non-Equity Incentive Plan | $208,797 |
|---|---|
| Option Awards | $1,626,760 |
| Salary | $485,574 |
| Other | $26,088 |
| Total | $2,349,219 |
Sheridan received $1.6M in option awards, accounting for 69% of the total pay in 2018.
Sheridan also received $208.8K in non-equity incentive plan, $485.6K in salary and $26.1K in other compensation.
Rankings
In 2018, William P. Sheridan's compensation ranked 4,940th out of 14,244 executives tracked by ExecPay. In other words, Sheridan earned more than 65.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,940 out of 14,244 | 65th |
Division Manufacturing | 1,859 out of 5,765 | 68th |
Major group Chemicals And Allied Products | 680 out of 2,128 | 68th |
Industry group Drugs | 570 out of 1,817 | 69th |
Industry Biological Products, Except Diagnostic Substances | 115 out of 339 | 66th |
Pay ratio
| William P. Sheridan's Pay | $2,349,219 |
|---|---|
| Median Employee's Pay | $205,224 |
| Pay Ratio | 11to 1 |
In 2018, the annual total compensation of William P. Sheridan was $2,349,219.
The annual total compensation of the median employee at BioCryst Pharmaceuticals was $205,224.
The ratio of William P. Sheridan's pay to the pay of median employee was therefore 11 to one.
Sheridan's colleagues
We found four more compensation records of executives who worked with William P. Sheridan at BioCryst Pharmaceuticals in 2018.
2018
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2018
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2018
Yarlagadda Babu
BioCryst Pharmaceuticals
Senior Vice President of Drug Discovery
2018
Lynne Powell
BioCryst Pharmaceuticals